Local Sparta Rehab Releases New Guidance on Starting Suboxone® After Oxycodone

SPARTA, TN - March 30, 2026 - PRESSADVANTAGE -

ReVIDA® Recovery, a medication-assisted treatment center in Sparta, has published a new educational blog designed to answer one of the most common questions people have when seeking treatment for opioid use disorder: how long they should wait to take Suboxone® after oxycodone. The new resource explains why that transition cannot be based on guesswork alone, what factors can affect timing, and how treatment providers help patients move into care as safely as possible.

The blog focuses on the period between stopping oxycodone and beginning Suboxone® (buprenorphine), a stage that can feel uncertain and intimidating for people who are ready to get help but are afraid of making the wrong move. ReVIDA’s article explains that Suboxone® is usually started once withdrawal is clearly underway, but that the exact timing varies from person to person depending on metabolism, the type of oxycodone involved, frequency of use, and whether counterfeit pills may be part of the picture.

That message is especially relevant in Tennessee, where opioid use continues to affect individuals, families, and communities statewide. ReVIDA® notes in the blog that Tennessee’s opioid dispensing rates remain among the highest in the nation, with 59 out of every 100 prescriptions dispensed at retail pharmacies in the state being for opioids. For people in White County and the surrounding area, practical information about safe treatment can make a meaningful difference in their decision to reach out for help.

A major focus of the article is the way oxycodone and Suboxone® interact in the body. While both affect opioid receptors in the brain, they do so differently. Oxycodone is a full opioid agonist, while buprenorphine is a partial opioid agonist with high receptor affinity. Because buprenorphine binds so tightly, it can displace oxycodone from the receptors if it is taken too early. That sudden shift can trigger precipitated withdrawal, which the blog describes as immediate and severe compared to the slower onset of natural withdrawal.

The resource is meant to reduce fear by showing that this reaction is not random and does not mean treatment has failed. Instead, it means the transition has to be timed carefully and guided by observable signs. As the blog states, “Navigating the timeline between oxycodone and Suboxone® (buprenorphine) doesn’t have to be a guessing game.” The article goes on to explain that trained providers rely on the Clinical Opiate Withdrawal Scale, or COWS, to assess whether a patient is physically ready to begin Suboxone® safely.

Rather than using a fixed number of hours for every person, the COWS scale looks at objective symptoms such as elevated pulse, dilated pupils, restlessness, gastrointestinal upset, sweating, tremors, and other visible signs of withdrawal. This clinical approach helps providers confirm that opioid receptors are ready for a safer transition and gives patients a clearer understanding of what to expect.

ReVIDA’s blog also addresses an increasingly important concern involving counterfeit pills. In many cases, substances sold as oxycodone may actually contain fentanyl, which can stay in the body longer and change how withdrawal appears. The article encourages people to be honest with their provider about where the substance came from so care teams can better plan for a safer induction process.

In addition to explaining the science behind the transition, the blog highlights the role treatment professionals play in helping patients manage symptoms while they wait. ReVIDA explains that providers may use non-opioid medications, hydration guidance, and close clinical support to make the waiting period more manageable. That kind of structure can be critical for people who are afraid that discomfort or uncertainty will keep them from following through with treatment.

ReVIDA® Recovery serves patients in Sparta and across Tennessee through outpatient treatment for opioid use disorder. The organization provides medication-assisted treatment, counseling, and practical support tailored to each patient’s situation. Same-day appointments are often available, and Medicaid is accepted. To learn more about their programming, contact 423-631-0432.

###

For more information about ReVIDA® Recovery Sparta, contact the company here:

ReVIDA® Recovery Sparta
Fancy Kilgore
(931) 222-0139
generalinfo@revidarecovery.com
161 Mose Dr
Sparta, TN 38583